Magnesium Sulfate Prevents Cerebral Palsy in Premature Babies: Cochrane Review
• A Cochrane review confirms that magnesium sulfate infusions given to women at risk of premature birth can prevent cerebral palsy in their babies.
• The inexpensive treatment, costing approximately $6.50 per dose, has been recommended by the WHO since 2015 for women at risk of premature birth before 32 weeks.
• A program in England demonstrated that widespread use of magnesium sulfate resulted in an estimated 385 fewer cases of cerebral palsy between 2018 and 2023.
• Researchers call for increased global implementation and further studies to optimize the drug's administration, especially in low-resource settings.
© Copyright 2025. All Rights Reserved by MedPath